You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

Kedrion is a leading biopharmaceutical company that specializes in the development, production and distribution of plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as immune system deficiencies and coagulation disorders.

With a commercial presence in 100 countries, we operate through a fully integrated business model from the collection of plasma in our own centers in the United States and in Hungary to fractionation and production in our manufacturing facilities located in Italy, Hungary and the United States.

Financial reports

About Kedrion - Front Image

    Consolidated First Half Results 2020

    Consolidated Financial Statements 2019

    CONSOLIDATED FIRST HALF RESULTS 2019

    Consolidated Financial Statements 2018

    CONSOLIDATED FIRST HALF RESULTS 2018

KEDRION NOTES

Contact & Email alerts

Subscribe to the service in order to receive our news

For more information please contact: investor@kedrion.com